Callegari Sylvie, Richter Frank, Chojnacka Katarzyna, Jans Daniel C, Lorenzi Isotta, Pacheu-Grau David, Jakobs Stefan, Lenz Christof, Urlaub Henning, Dudek Jan, Chacinska Agnieszka, Rehling Peter
Department of Cellular Biochemistry, University Medical Center Göttingen, Germany.
International Institute of Molecular and Cell Biology, Warsaw, Poland.
FEBS Lett. 2016 Dec;590(23):4147-4158. doi: 10.1002/1873-3468.12450. Epub 2016 Oct 26.
Hydrophobic inner mitochondrial membrane proteins with internal targeting signals, such as the metabolite carriers, use the carrier translocase (TIM22 complex) for transport into the inner membrane. Defects in this transport pathway have been associated with neurodegenerative disorders. While the TIM22 complex is well studied in baker's yeast, very little is known about the mammalian TIM22 complex. Using immunoprecipitation, we purified the human carrier translocase and identified a mitochondrial inner membrane protein TIM29 as a novel component, specific to metazoa. We show that TIM29 is a constituent of the 440 kDa TIM22 complex and interacts with oxidized TIM22. Our analyses demonstrate that TIM29 is required for the structural integrity of the TIM22 complex and for import of substrate proteins by the carrier translocase.
具有内部靶向信号的疏水性线粒体内膜蛋白,如代谢物载体,利用载体转位酶(TIM22复合体)转运至内膜。该转运途径的缺陷与神经退行性疾病有关。虽然TIM22复合体在酿酒酵母中已得到充分研究,但对哺乳动物的TIM22复合体却知之甚少。我们通过免疫沉淀纯化了人类载体转位酶,并鉴定出一种线粒体内膜蛋白TIM29作为后生动物特有的新组分。我们发现TIM29是440 kDa TIM22复合体的一个组成部分,并与氧化型TIM22相互作用。我们的分析表明,TIM29对于TIM22复合体的结构完整性以及载体转位酶对底物蛋白的导入是必需的。